Loading
Sarcoma Oncology Center
The Sarcoma Oncology Center in Santa Monica, the practice of Sant Chawla, offers sarcoma second opinions, clinical trials and multimodal treatment planning.
Overview
The Sarcoma Oncology Center is a sarcoma-focused practice in Santa Monica, California, offering second opinions, access to clinical trials and multimodal treatment planning; its director Sant Chawla led the aldoxorubicin trials and co-founded Gemini Therapeutics. Patient-bookable.
Location
Santa Monica, US
Type
hospital
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#429 · 12 points (0 Newsweek + 0 NCI + 12 from 6 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-15.
Matched to Sarcoma Oncology Center, including child institutions. 19 works · 114 citations · 79% open access · 37% clinical trials · 0% reviews.
Oncology works per year
62022
32023
32024
32025
42026
Most works
- Sant P. Chawla6 works
- Sant P. Chawla5 works
- Neal Shiv Chawla5 works
- Ania M. Moradkhani4 works
- Erlinda Maria Gordon4 works
- Vincent M. Chung3 works
- Victoria S. Chua-Alcala3 works
- Allyson J. Ocean3 works
- Andrea Wang‐Gillam2 works
- Harry Staszewski2 works
Most cited
People
1Connected
7Similar pages
- InstitutionDocrates Cancer Center
Shares Multidisciplinary tumour boards and the tag fcct-directory.
- CompanyPrivate Health Management
Shares Multidisciplinary tumour boards and the tag fcct-directory.
- CompanyPrivate Medical
Shares Multidisciplinary tumour boards and the tag fcct-directory.
- CompanyPathfinder Oncology
Shares Multidisciplinary tumour boards and the tag fcct-directory.
- InstitutionAsthra Health
Shares Multidisciplinary tumour boards and the tag fcct-directory.
- Key paperFirst-Line Aldoxorubicin vs Doxorubicin in Metastatic or Locally Advanced Unresectable Soft-Tissue Sarcoma: A Phase 2b Randomized Clinical Trial
Shares Aldoxorubicin, Aldoxorubicin versus investigator's choice in relapsed or refractory soft tissue sarcoma.
- TargetSQSTM1
- CompanySARC (Sarcoma Alliance for Research through Collaboration)
cancers
technologies
drugs
Phase 3Albumin-binding small-molecule prodrug of doxorubicin, intravenous
companies
trials
people
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
sarcomaoncology.com · 1
sijbrandijfoundation.org · 1
A source that has moved or gone is reported by the weekly link check. /audit/
ProvenanceLast edited 2026-09-17 · Jude Gomila · Mine institution networks (rows 110, 111) · diff · file
Sourced, not expert-reviewed